I believe you are getting a bargain here. Likely a sell off in relation to Think Equity exercising its over allotment of shares. They now have ~$28 million USD in the bank so they are almost trading at cash value. The previous trial data was good and now they have money to dose more patients for an eventual big pharma buyout. My guess is it will be Incyte down the road considering we are
...more